Survey of methods for measuring human anti-mouse antibodies. HAMA Survey Group
- PMID: 8403432
Survey of methods for measuring human anti-mouse antibodies. HAMA Survey Group
Abstract
Human anti-mouse antibodies (HAMA) methods were surveyed using a panel of 17 serum and two plasma specimens which were circulated to ten laboratories for analysis. The panel included HAMA-negative and HAMA-positive specimens (from patients given a variety of mouse monoclonal antibodies) and a specimen with a high rheumatoid factor titer. The participating laboratories used a diverse range of methods to determine HAMA and all three of the commercially available quantitative methods for HAMA were represented. The survey revealed significant differences in HAMA results among the different laboratories.
Similar articles
-
Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA).J Immunoassay. 1992;13(2):289-96. doi: 10.1080/15321819208021232. J Immunoassay. 1992. PMID: 1430244
-
The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.Cancer Res. 2000 Apr 1;60(7):1921-6. Cancer Res. 2000. PMID: 10766181 Clinical Trial.
-
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen.Clin Chem. 1989 Jan;35(1):146-51. Clin Chem. 1989. PMID: 2642761
-
Human anti-mouse antibodies.Arch Pathol Lab Med. 2000 Jun;124(6):921-3. doi: 10.5858/2000-124-0921-HAMA. Arch Pathol Lab Med. 2000. PMID: 10835540 Review.
-
Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseases.Nucl Med Commun. 1988 Nov;9(11):919-30. doi: 10.1097/00006231-198811000-00009. Nucl Med Commun. 1988. PMID: 3075018 Review.
Cited by
-
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.Br J Cancer. 2007 Feb 26;96(4):567-74. doi: 10.1038/sj.bjc.6603567. Epub 2007 Feb 6. Br J Cancer. 2007. PMID: 17285137 Free PMC article. Clinical Trial.
-
Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays.Cancer Immunol Immunother. 1995 Jan;40(1):24-30. doi: 10.1007/BF01517232. Cancer Immunol Immunother. 1995. PMID: 7828165 Free PMC article.
-
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients.Cancer Immunol Immunother. 2008 May;57(5):677-84. doi: 10.1007/s00262-007-0406-0. Epub 2007 Oct 13. Cancer Immunol Immunother. 2008. PMID: 17934732 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources